Table 4.
IL-10 genotype frequencies in the complete cohort of MG patients (i.e., total MG), the subgroups of early and late onset MG and controls.
| Phenotype | Genotypes | Total MG N = 97 (%)a | Early onset N = 45 (%)b | Late onset N = 44 (%)b | Control N = 100 (%)a |
|---|---|---|---|---|---|
| High IL-10 expression | GCC/GCC | 11 (11.32) | 2 (4.0) | 9 (20.0) | 13 (13.0) |
|
| |||||
| Medium IL-10 expression | ACC/GCC | 23 (23.72) | 12 (27.0) | 10 (23.0) | 28 (28.0) |
| ATA/GCC | 24 (24.72) | 13 (29.0) | 9 (20.0) | 17 (17.0) | |
|
| |||||
| Low IL-10 expression | ACC/ACC | 12 (12.42) | 5 (11.0) | 6 (14.0) | 15 (15.0) |
| ATA/ATA | 6 (6.2) | 4 (9.0) | 2 (5.0) | 9 (9.0) | |
| ATA/ACC | 21 (21.62) | 9 (20.0) | 8 (18.0) | 18 (18.0) | |
aAnalysis was not successful for a subset of samples.
bEight MG samples were of unknown age at onset.